Get the Stockscreener App
0.2405
5.91%
-0.0151
After Hours:
.25
0.0095
+3.95%
Context Therapeutics Inc Stock (CNTX) Forecast
The Context Therapeutics Inc (CNTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.9185, representing a +1,114% increase from the current price of $0.2405. The highest analyst price target is $5.706, and the lowest is $0.1311.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNTX Price Target
Average 2.9185
(+1,114% Upside)
Is Context Therapeutics Inc (CNTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.03 | Buy |
| STOCH(9,6) | 8.9799 | Buy |
| STOCHRSI(14) | 22.00 | Neutral |
| MACD(12,26) | -0.038 | Sell |
| ADX(14) | 38.16 | Sell |
| William %R | -96.26 | Buy |
| CCI(14) | -97.56 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.296
Sell
|
0.2889
Sell
|
| MA20 |
0.3226
Sell
|
0.3163
Sell
|
| MA50 |
0.3859
Sell
|
0.4378
Sell
|
| MA100 |
0.7136
Sell
|
0.7414
Sell
|
| MA200 |
1.5289
Sell
|
1.0081
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CNTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CNTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.03 indicates that CNTX is oversold. This indicates that CNTX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 8.9799 indicates that CNTX is oversold. This indicates that CNTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 22 indicates that CNTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.16 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.56 indicates that CNTX is still oversold but not to an extreme extent.
Long-term CNTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Context Therapeutics Inc financial reports and earnings history, Context Therapeutics Inc (CNTX) stock could reach $0.1707 by 2030, $9.3192 by 2040 and $20.70 by 2050. See the projected annual prices until 2050 of the Context Therapeutics Inc stock below:
- Context Therapeutics Inc (CNTX) is expected to reach an average price of $4.5994 in 2035, with a high prediction of $4.8361 and a low estimate of $4.6294. This indicates an $1,812% rise from the last recorded price of $0.2405.
- Context Therapeutics Inc (CNTX) stock is projected to chart a bullish course in 2040, with an average price target of $9.2642, representing an $3,752% surge from its current level. The forecast ranges from a conservative $9.2642 to a sky-high $9.3192.
- Our analysts predict Context Therapeutics Inc (CNTX) to jump 6,121% by 2045, soaring from $14.97 to an average price of $14.96, potentially reaching $15.33. While $14.97 is the low estimate, the potential upside is significant.
- Context Therapeutics Inc (CNTX) stock is expected to climb by 2050, reaching an average of $20.61, a $8,471% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.70 and $20.71, respectively, highlighting the market's uncertainty.
Context Therapeutics Inc Stock (CNTX) Year by Year Forecast
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2026
The predicted value for Context Therapeutics Inc (CNTX) in 2026 is set at an average of $2.8777. Estimates vary from a peak of $5.706 to a trough of $0.0494, indicating an +1,097% surge from the present price of $0.2405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.2331 | $0.1311 | $5.706 | -3.07% |
| December, 2026 | $2.5486 | $2.2198 | $2.2486 | +959.69% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Context Therapeutics Inc (CNTX) is $2.8225, with a high forecast of $3.1998 and a low forecast of $2.4452. This indicates an +1,074% increase from the last price of $0.2405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9702 | $2.8815 | $2.8903 | +1,135% |
| February, 2027 | $3.1519 | $2.9931 | $3.0019 | +1,211% |
| March, 2027 | $2.6065 | $2.8545 | $3.0248 | +983.77% |
| April, 2027 | $2.9881 | $2.4452 | $2.5494 | +1,142% |
| May, 2027 | $2.9327 | $3.211 | $3.1998 | +1,119% |
| June, 2027 | $2.7244 | $2.6985 | $2.6844 | +1,033% |
| July, 2027 | $2.506 | $2.5331 | $2.439 | +942.01% |
| August, 2027 | $2.5606 | $2.6481 | $2.483 | +964.70% |
| September, 2027 | $2.5123 | $2.5823 | $2.4623 | +944.60% |
| October, 2027 | $3.1239 | $2.6052 | $2.8539 | +1,199% |
| November, 2027 | $2.9985 | $3.2248 | $3.1756 | +1,147% |
| December, 2027 | $2.9502 | $3.0314 | $2.9568 | +1,127% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2028
In 2028, Context Therapeutics Inc (CNTX) is projected to reach an average price of $2.7575, with a high projection of $3.3769 and a low estimate of $2.1381. This indicates an +1,047% rise from the last price of $0.2405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.3651 | $2.826 | $3.2598 | +1,299% |
| February, 2028 | $3.3034 | $3.3363 | $3.3769 | +1,274% |
| March, 2028 | $3.0561 | $3.0681 | $3.2743 | +1,171% |
| April, 2028 | $3.1297 | $3.101 | $3.1017 | +1,201% |
| May, 2028 | $3.2521 | $3.1427 | $3.1544 | +1,252% |
| June, 2028 | $3.1649 | $3.1631 | $3.1261 | +1,216% |
| July, 2028 | $2.7906 | $2.8205 | $3.1296 | +1,060% |
| August, 2028 | $2.2522 | $2.3722 | $2.3635 | +836.48% |
| September, 2028 | $2.3639 | $2.1381 | $2.2476 | +882.91% |
| October, 2028 | $2.3685 | $2.3897 | $2.3397 | +884.81% |
| November, 2028 | $2.4701 | $2.3872 | $2.3401 | +927.08% |
| December, 2028 | $1.9518 | $2.2017 | $2.236 | +711.56% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2029
The 2029 price forecast for Context Therapeutics Inc Stock (CNTX) is $1.1007 on average, with a high prediction of $2.198 and a low estimate of $0.00342. This represents an +357.69% increase from the previous price of $0.2405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.9664 | $2.0447 | $2.1146 | +717.62% |
| February, 2029 | $2.298 | $2.1493 | $2.198 | +855.53% |
| March, 2029 | $1.9797 | $2.1697 | $2.188 | +723.16% |
| April, 2029 | $2.0242 | $1.9055 | $1.8843 | +741.66% |
| May, 2029 | $1.8861 | $1.936 | $1.9201 | +684.22% |
| June, 2029 | $1.6576 | $1.7547 | $1.6947 | +589.24% |
| July, 2029 | $1.2822 | $1.5022 | $1.6005 | +433.14% |
| August, 2029 | $0.8539 | $1.3939 | $1.2809 | +255.03% |
| September, 2029 | $0.6555 | $0.7355 | $0.6769 | +172.57% |
| October, 2029 | $0.7301 | $0.6572 | $0.5584 | +203.58% |
| November, 2029 | $0.3218 | $0.3618 | $0.463 | +33.79% |
| December, 2029 | $0.0637 | $0.00342 | $0.3195 | -73.53% |
Context Therapeutics Inc Stock (CNTX) Price Forecast for 2030
Context Therapeutics Inc Stock (CNTX) is expected to reach an average price of $0.5519 in 2030, with a high forecast of $1.0905 and a low forecast of $0.0134. This signifies an +129.50% surge from the last price of $0.2405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.468 | $0.1713 | $0.1707 | +94.60% |
| February, 2030 | $0.2197 | $0.3197 | $0.3009 | -8.66% |
| March, 2030 | $0.2413 | $0.0134 | $0.3473 | +0.35% |
| April, 2030 | $0.7159 | $0.3929 | $0.5901 | +197.68% |
| May, 2030 | $0.7876 | $0.9676 | $0.9547 | +227.47% |
| June, 2030 | $1.0559 | $0.9605 | $0.991 | +339.06% |
| July, 2030 | $1.0824 | $1.0826 | $1.046 | +350.07% |
| August, 2030 | $1.2035 | $1.1207 | $1.0905 | +400.41% |
| September, 2030 | $0.8631 | $0.9301 | $1.0012 | +258.86% |
| October, 2030 | $0.9688 | $0.8929 | $0.9119 | +302.84% |
| November, 2030 | $1.0208 | $1.0105 | $0.9635 | +324.44% |
| December, 2030 | $0.618 | $0.8379 | $0.9161 | +156.95% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):